Trade Dr. Martens plc - DOCS.L CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.0440 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.023178% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.00126% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | GBP | ||||||||
Margin | 20% | ||||||||
Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Dr Martens PLC ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 1.525 |
Open* | 1.406 |
1-Year Change* | -34.97% |
Day's Range* | 1.347 - 1.422 |
52 wk Range | 1.27-2.95 |
Average Volume (10 days) | 1.04M |
Average Volume (3 months) | 35.69M |
Market Cap | 1.56B |
P/E Ratio | 8.85 |
Shares Outstanding | 1.00B |
Revenue | 957.00M |
EPS | 0.18 |
Dividend (Yield %) | 1.99616 |
Beta | -100.00K |
Next Earnings Date | Jun 1, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
May 31, 2023 | 1.5250 | 0.0250 | 1.67% | 1.5000 | 1.5895 | 1.4800 |
May 30, 2023 | 1.5260 | -0.0085 | -0.55% | 1.5345 | 1.5560 | 1.4570 |
May 26, 2023 | 1.5885 | -0.0590 | -3.58% | 1.6475 | 1.6475 | 1.5505 |
May 25, 2023 | 1.6655 | 0.0840 | 5.31% | 1.5815 | 1.6725 | 1.5815 |
May 24, 2023 | 1.6195 | -0.0150 | -0.92% | 1.6345 | 1.6345 | 1.5645 |
May 23, 2023 | 1.6575 | 0.0320 | 1.97% | 1.6255 | 1.6585 | 1.6225 |
May 22, 2023 | 1.6625 | -0.0400 | -2.35% | 1.7025 | 1.7035 | 1.6505 |
May 19, 2023 | 1.7165 | 0.0200 | 1.18% | 1.6965 | 1.7355 | 1.6945 |
May 18, 2023 | 1.7055 | 0.0220 | 1.31% | 1.6835 | 1.7115 | 1.6725 |
May 17, 2023 | 1.6835 | -0.0040 | -0.24% | 1.6875 | 1.6875 | 1.6415 |
May 16, 2023 | 1.6875 | 0.0120 | 0.72% | 1.6755 | 1.6925 | 1.6745 |
May 15, 2023 | 1.6915 | 0.0400 | 2.42% | 1.6515 | 1.6915 | 1.6475 |
May 12, 2023 | 1.6545 | 0.0080 | 0.49% | 1.6465 | 1.6695 | 1.6365 |
May 11, 2023 | 1.6525 | -0.0120 | -0.72% | 1.6645 | 1.6865 | 1.6375 |
May 10, 2023 | 1.6645 | 0.0200 | 1.22% | 1.6445 | 1.6765 | 1.6335 |
May 9, 2023 | 1.6445 | -0.0050 | -0.30% | 1.6495 | 1.6705 | 1.6305 |
May 5, 2023 | 1.6475 | 0.0240 | 1.48% | 1.6235 | 1.6685 | 1.6045 |
May 4, 2023 | 1.6325 | 0.0160 | 0.99% | 1.6165 | 1.6395 | 1.5675 |
May 3, 2023 | 1.6195 | 0.0030 | 0.19% | 1.6165 | 1.6605 | 1.5875 |
May 2, 2023 | 1.6365 | -0.0390 | -2.33% | 1.6755 | 1.6765 | 1.6245 |
Dr. Martens plc Events
Time (UTC) | Country | Event |
---|---|---|
Friday, July 14, 2023 | ||
Time (UTC) 08:30 | Country GB
| Event Dr Martens PLC Annual Shareholders Meeting Dr Martens PLC Annual Shareholders MeetingForecast -Previous - |
Wednesday, November 22, 2023 | ||
Time (UTC) 10:59 | Country GB
| Event Half Year 2024 Dr Martens PLC Earnings Release Half Year 2024 Dr Martens PLC Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 908.3 | 773 | 672.2 | 454.4 | 348.6 |
Revenue | 908.3 | 773 | 672.2 | 454.4 | 348.6 |
Cost of Revenue, Total | 329.5 | 302.5 | 270.7 | 193.8 | 162.6 |
Gross Profit | 578.8 | 470.5 | 401.5 | 260.6 | 186 |
Total Operating Expense | 679 | 660.5 | 529.7 | 386.4 | 308.4 |
Selling/General/Admin. Expenses, Total | 315.8 | 246.3 | 217 | 175.6 | 136 |
Depreciation / Amortization | 36.7 | 33.9 | 28.9 | 9.8 | 5.6 |
Interest Expense (Income) - Net Operating | -3.2 | -3.8 | 0.5 | 1.2 | 1.4 |
Unusual Expense (Income) | 0.2 | 81.6 | 12.6 | 6 | 2.8 |
Operating Income | 229.3 | 112.5 | 142.5 | 68 | 40.2 |
Interest Income (Expense), Net Non-Operating | -15 | -41.6 | -41.5 | -39.1 | -39.5 |
Net Income Before Taxes | 214.3 | 70.9 | 101 | 28.9 | 0.7 |
Net Income After Taxes | 181.2 | 35.7 | 74.8 | 17.2 | -5.7 |
Net Income Before Extra. Items | 181.2 | 35.7 | 74.8 | 17.2 | -5.7 |
Net Income | 181.2 | 35.7 | 74.8 | 17.2 | -5.7 |
Income Available to Common Excl. Extra. Items | 181.2 | 35.7 | 74.8 | 17.2 | -5.7 |
Income Available to Common Incl. Extra. Items | 181.2 | 35.7 | 74.8 | 17.2 | -5.7 |
Diluted Net Income | 181.2 | 35.7 | 74.8 | 17.2 | -5.7 |
Diluted Weighted Average Shares | 1002.9 | 1000.4 | 1000 | 1000 | 1000 |
Diluted EPS Excluding Extraordinary Items | 0.18068 | 0.03569 | 0.0748 | 0.0172 | -0.0057 |
Dividends per Share - Common Stock Primary Issue | 0.055 | 0 | 0 | 0 | |
Diluted Normalized EPS | 0.18084 | 0.07676 | 0.08413 | 0.02077 | -0.00388 |
Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | Sep 2020 | |
---|---|---|---|---|---|
Total revenue | 418.6 | 538.4 | 369.9 | 454.8 | 318.2 |
Revenue | 418.6 | 538.4 | 369.9 | 454.8 | 318.2 |
Cost of Revenue, Total | 160.8 | 186.2 | 143.3 | 170.6 | 131.9 |
Gross Profit | 257.8 | 352.2 | 226.6 | 284.2 | 186.3 |
Total Operating Expense | 353.3 | 377.8 | 301.2 | 407.1 | 253.4 |
Selling/General/Admin. Expenses, Total | 169 | 178 | 137.8 | 146.3 | 100 |
Depreciation / Amortization | 23.3 | 18.7 | 18 | 16.6 | 17.3 |
Interest Expense (Income) - Net Operating | 0.2 | -5.3 | 2.1 | -3.9 | 0.1 |
Unusual Expense (Income) | 0.2 | 0 | 77.5 | 4.1 | |
Operating Income | 65.3 | 160.6 | 68.7 | 47.7 | 64.8 |
Interest Income (Expense), Net Non-Operating | -7.4 | -7.6 | -7.4 | -18.7 | -22.9 |
Net Income Before Taxes | 57.9 | 153 | 61.3 | 29 | 41.9 |
Net Income After Taxes | 44.7 | 132.6 | 48.6 | 6.2 | 29.5 |
Net Income Before Extra. Items | 44.7 | 132.6 | 48.6 | 6.2 | 29.5 |
Net Income | 44.7 | 132.6 | 48.6 | 6.2 | 29.5 |
Income Available to Common Excl. Extra. Items | 44.7 | 132.6 | 48.6 | 6.2 | 29.5 |
Income Available to Common Incl. Extra. Items | 44.7 | 132.6 | 48.6 | 6.2 | 29.5 |
Diluted Net Income | 44.7 | 132.6 | 48.6 | 6.2 | 29.5 |
Diluted Weighted Average Shares | 1004.7 | 1003.2 | 1002.6 | 1000.8 | 1000 |
Diluted EPS Excluding Extraordinary Items | 0.04449 | 0.13218 | 0.04847 | 0.0062 | 0.0295 |
Dividends per Share - Common Stock Primary Issue | 0.0156 | 0.0428 | 0 | ||
Diluted Normalized EPS | 0.04449 | 0.13235 | 0.04847 | 0.05653 | 0.03239 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 443.6 | 274.8 | 277.2 | 165.5 | 169.3 |
Cash and Short Term Investments | 228 | 113.6 | 117.2 | 58.4 | 86.4 |
Cash & Equivalents | 228 | 113.6 | 117.2 | 58.4 | 86.4 |
Total Receivables, Net | 87.6 | 56 | 65 | 48.9 | 36.7 |
Accounts Receivable - Trade, Net | 75.9 | 50.7 | 55.5 | 40.8 | 29.7 |
Total Inventory | 123 | 101.5 | 90 | 53.9 | 39.8 |
Prepaid Expenses | 4.1 | 3.4 | 3.5 | 4.2 | 6.4 |
Other Current Assets, Total | 0.9 | 0.3 | 1.5 | 0.1 | 0 |
Total Assets | 859.1 | 652.8 | 656.5 | 450.2 | 445.8 |
Property/Plant/Equipment, Total - Net | 143.8 | 110 | 114.7 | 26.9 | 23.6 |
Property/Plant/Equipment, Total - Gross | 239 | 181.6 | 159.2 | 47.6 | 36.3 |
Accumulated Depreciation, Total | -95.2 | -71.6 | -44.5 | -20.7 | -12.7 |
Goodwill, Net | 240.7 | 240.7 | 240.7 | 240.7 | 240.7 |
Intangibles, Net | 21.4 | 20.1 | 16.5 | 11.1 | 7.8 |
Other Long Term Assets, Total | 9.6 | 7.2 | 7.4 | 6 | 4.4 |
Total Current Liabilities | 155 | 152.3 | 130.7 | 64.5 | 55.6 |
Accounts Payable | 52.4 | 52.6 | 33.4 | 20 | 19.6 |
Accrued Expenses | 76.8 | 75.1 | 50.1 | 27.6 | 22.3 |
Notes Payable/Short Term Debt | 0 | 0 | 20 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 19.8 | 18.2 | 21.8 | 3.2 | 4.1 |
Other Current Liabilities, Total | 6 | 6.4 | 5.4 | 13.7 | 9.6 |
Total Liabilities | 530.9 | 502.1 | 586 | 458.6 | 475.2 |
Total Long Term Debt | 374 | 348.2 | 453.8 | 387.5 | 416 |
Long Term Debt | 280.9 | 281.6 | 387.2 | 387.5 | 416 |
Capital Lease Obligations | 93.1 | 66.6 | 66.6 | 0 | 0 |
Other Liabilities, Total | 1.9 | 1.6 | 1.5 | 6.6 | 3.6 |
Total Equity | 328.2 | 150.7 | 70.5 | -8.4 | -29.4 |
Common Stock | 10 | 10 | 0 | 0 | 0 |
Additional Paid-In Capital | 0 | 0 | 10 | ||
Retained Earnings (Accumulated Deficit) | 311.3 | 138.1 | 58.9 | -15.9 | -43.6 |
Treasury Stock - Common | 0 | 0 | 0 | ||
Other Equity, Total | 6.9 | 2.6 | 11.6 | 7.5 | 4.2 |
Total Liabilities & Shareholders’ Equity | 859.1 | 652.8 | 656.5 | 450.2 | 445.8 |
Total Common Shares Outstanding | 1000.22 | 1000 | 1000 | 1000 | 1000 |
Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | Sep 2020 | |
---|---|---|---|---|---|
Total Current Assets | 523.6 | 443.6 | 314 | 274.8 | 372.6 |
Cash and Short Term Investments | 133 | 228 | 113.2 | 113.6 | 146.8 |
Cash & Equivalents | 133 | 228 | 113.2 | 113.6 | 146.8 |
Total Receivables, Net | 114.2 | 87.6 | 73.9 | 56 | 88.6 |
Accounts Receivable - Trade, Net | 95.8 | 75.9 | 64.2 | 50.7 | 76.6 |
Total Inventory | 261.4 | 123 | 119.8 | 101.5 | 128 |
Prepaid Expenses | 8.5 | 4.1 | 6.7 | 3.4 | 5 |
Other Current Assets, Total | 6.5 | 0.9 | 0.4 | 0.3 | 4.2 |
Total Assets | 981.3 | 859.1 | 709.6 | 652.8 | 750.8 |
Property/Plant/Equipment, Total - Net | 181.6 | 143.8 | 125.6 | 110 | 111 |
Property/Plant/Equipment, Total - Gross | 239 | 212.2 | 181.6 | 170.9 | |
Accumulated Depreciation, Total | -95.2 | -86.6 | -71.6 | -59.9 | |
Goodwill, Net | 240.7 | 240.7 | 240.7 | 240.7 | 240.7 |
Intangibles, Net | 24.4 | 21.4 | 20.6 | 20.1 | 19.1 |
Other Long Term Assets, Total | 11 | 9.6 | 8.7 | 7.2 | 7.4 |
Total Current Liabilities | 218.9 | 155 | 140.2 | 152.3 | 183.5 |
Accounts Payable | 105.7 | 52.4 | 46 | 52.6 | 83.5 |
Accrued Expenses | 75.1 | 76.8 | 66.8 | 75.1 | 53.9 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 20 |
Current Port. of LT Debt/Capital Leases | 28.4 | 19.8 | 20 | 18.2 | 19.5 |
Other Current Liabilities, Total | 9.7 | 6 | 7.4 | 6.4 | 6.6 |
Total Liabilities | 634.8 | 530.9 | 506 | 502.1 | 650.4 |
Total Long Term Debt | 410.6 | 374 | 364.1 | 348.2 | 465.3 |
Long Term Debt | 292.9 | 280.9 | 285.3 | 281.6 | 396 |
Capital Lease Obligations | 117.7 | 93.1 | 78.8 | 66.6 | 69.3 |
Other Liabilities, Total | 4.5 | 1.9 | 1.7 | 1.6 | 1.6 |
Total Equity | 346.5 | 328.2 | 203.6 | 150.7 | 100.4 |
Common Stock | 10 | 10 | 10 | 10 | 0 |
Additional Paid-In Capital | 0 | ||||
Retained Earnings (Accumulated Deficit) | 316.2 | 311.3 | 188.6 | 138.1 | 93.2 |
Treasury Stock - Common | -0.6 | ||||
Other Equity, Total | 20.3 | 6.9 | 5 | 2.6 | 7.8 |
Total Liabilities & Shareholders’ Equity | 981.3 | 859.1 | 709.6 | 652.8 | 750.8 |
Total Common Shares Outstanding | 1000.56 | 1000.22 | 1000 | 1000 | 1000 |
Deferred Income Tax | 0.8 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 181.2 | 35.7 | 74.8 | 17.2 | -5.7 |
Cash From Operating Activities | 184.4 | 160.2 | 121.4 | 56 | 46 |
Cash From Operating Activities | 36.9 | 35 | 29.5 | 10.6 | 6.5 |
Non-Cash Items | 17 | 49.3 | 42.4 | 41 | 34.2 |
Cash Taxes Paid | 8.1 | -2.1 | 8.3 | 0.4 | -0.9 |
Cash Interest Paid | 10.8 | 12.8 | 5.4 | 5.2 | 5.3 |
Changes in Working Capital | -50.7 | 40.2 | -25.3 | -12.8 | 11 |
Cash From Investing Activities | -25 | -18.6 | -21.9 | -17.1 | -16.4 |
Capital Expenditures | -25 | -18.6 | -21.9 | -17.1 | -16.4 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | ||
Cash From Financing Activities | -47 | -132.9 | -44 | -69.3 | -9.3 |
Financing Cash Flow Items | -10.8 | -12.8 | -5.4 | -5.2 | -5.3 |
Issuance (Retirement) of Stock, Net | 0 | -303.6 | -35 | -60 | 0 |
Issuance (Retirement) of Debt, Net | -24 | 183.5 | -3.6 | -4.1 | -4 |
Foreign Exchange Effects | 2 | -12.3 | 3.3 | 2.4 | -1.1 |
Net Change in Cash | 114.4 | -3.6 | 58.8 | -28 | 19.2 |
Total Cash Dividends Paid | -12.2 |
Sep 2022 | Mar 2022 | Sep 2021 | Mar 2021 | Sep 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | 44.7 | 181.2 | 48.6 | 35.7 | 29.5 |
Cash From Operating Activities | -22.7 | 184.4 | 23.9 | 160.2 | 65.4 |
Cash From Operating Activities | 23.3 | 36.9 | 18 | 35 | 18.4 |
Non-Cash Items | 10.6 | 17 | 11.3 | 49.3 | 23 |
Cash Taxes Paid | 0.9 | 8.1 | 7.9 | -2.1 | -1.7 |
Cash Interest Paid | 4.2 | 10.8 | 4.3 | 12.8 | 4.9 |
Changes in Working Capital | -101.3 | -50.7 | -54 | 40.2 | -5.5 |
Cash From Investing Activities | -19.3 | -25 | -10.1 | -18.6 | -11.6 |
Capital Expenditures | -19.3 | -25 | -10.1 | -18.6 | -8.2 |
Other Investing Cash Flow Items, Total | 0 | -3.4 | |||
Cash From Financing Activities | -57.6 | -47 | -15.8 | -132.9 | -22.3 |
Financing Cash Flow Items | -4.2 | -10.8 | -4.3 | -12.8 | -4.9 |
Issuance (Retirement) of Stock, Net | 0 | 0 | -303.6 | 0 | |
Issuance (Retirement) of Debt, Net | -10.6 | -24 | -11.5 | 183.5 | -17.4 |
Foreign Exchange Effects | 4.6 | 2 | 1.6 | -12.3 | -1.9 |
Net Change in Cash | -95 | 114.4 | -0.4 | -3.6 | 29.6 |
Total Cash Dividends Paid | -42.8 | -12.2 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Permira Advisers LLP | Private Equity | 36.3845 | 364142440 | 0 | 2022-05-31 | LOW |
GIC Private Limited | Sovereign Wealth Fund | 4.2114 | 42148324 | 0 | 2022-05-31 | LOW |
Artemis Investment Management LLP | Investment Advisor/Hedge Fund | 2.8333 | 28356330 | 14321519 | 2022-12-15 | MED |
T. Rowe Price Associates, Inc. | Investment Advisor | 2.1889 | 21907032 | 2696660 | 2022-12-15 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.7552 | 17566569 | 2732376 | 2023-05-01 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.7452 | 17465988 | 66870 | 2022-12-15 | LOW |
Jupiter Asset Management Ltd. | Investment Advisor/Hedge Fund | 1.5265 | 15277892 | -634189 | 2022-12-12 | LOW |
Columbia Threadneedle Investments (UK) | Investment Advisor/Hedge Fund | 1.4772 | 14784023 | -126648 | 2022-12-12 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 1.3997 | 14008399 | -8677 | 2023-05-01 | LOW |
Wilson (Kenneth) | Individual Investor | 1.1213 | 11222226 | 178 | 2023-05-11 | LOW |
T. Rowe Price International Ltd | Investment Advisor/Hedge Fund | 1.1024 | 11033105 | 2278196 | 2022-12-15 | MED |
Franklin Mutual Advisers, LLC | Investment Advisor/Hedge Fund | 1.0793 | 10801883 | 3058257 | 2023-04-30 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.0204 | 10211864 | -37880 | 2023-05-01 | LOW |
Hargreaves Lansdown Fund Managers Ltd. | Insurance Company | 0.8567 | 8573590 | 1523884 | 2023-03-31 | LOW |
Martin Currie Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.8274 | 8281098 | 636368 | 2022-12-15 | LOW |
M & G Investment Management Ltd. | Investment Advisor | 0.7923 | 7929521 | -60098 | 2023-05-01 | LOW |
Mason (Paul) | Individual Investor | 0.7869 | 7875000 | 0 | 2022-03-31 | |
Fidelity International | Investment Advisor | 0.7714 | 7720223 | 6221734 | 2023-05-01 | LOW |
Eurizon Capital SGR S.p.A. | Investment Advisor/Hedge Fund | 0.6875 | 6880893 | 281365 | 2022-12-12 | MED |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.6601 | 6606478 | 4896 | 2023-05-01 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com Group535K+
Traders
87K+
Active clients monthly
$113M+
Monthly investing volume
$64M+
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Dr. Martens plc Company profile
About Dr Martens PLC
Dr. Martens plc is a United Kingdom-based company that designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
Financial summary
BRIEF: For the six months ended 30 September 2021, Dr Martens PLC revenues increased 16% to £369.9M. Net income increased 65% to £48.6M. Revenues reflect Americas segment increase of 44% to £147.5M, Americas segment increase of 44% to £147.5M, Retail Sales - Total increase of 92% to £65.9M, Online Sales - Total increase of 10% to £82.6M. Net income benefited from Interest expense decrease of 75% to £5.1M (expense). Dividend per share totaled to £0.01.
Industry: | Footwear (NEC) |
28 Jamestown Rd
Camden
NW1 7BY
Income Statement
- Annual
- Quarterly
News

USD/TRY forecast: Turkish lira under pressure from high inflation and low rates
We look at some of the latest USD/TRY predictions as the Turkish lira hits record lows.
17:07, 1 June 2023
Nvidia’s 5-year stock forecast: Will the chipmaker remain at record highs?
Nvidia has been the winner of the AI race, being the first chip-maker to hit a $1tn market cap. Will the growth continue?
07:46, 31 May 2023
Google stock forecast 2023-2025
What is the outlook for the tech giant, following a tumultuous 2022?
18:02, 30 May 2023
USD forecast: DXY slides in risk-off market sentiment
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
16:10, 24 May 2023
Oil price forecast: Will WTI and Brent regain momentum in 2023?
Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.
11:38, 22 May 2023
Weekly Roundup: Tech stocks lead the way
US stocks push higher as risk appetite surges despite the uncertainty
13:39, 19 May 2023
USD/JPY continues to build higher towards 138
USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher
11:50, 17 May 2023People also watch
Still looking for a broker you can trust?
Join the 535.000+ traders worldwide that chose to trade with Capital.com